Wellington Management Group
FOLD

Wellington Management Group’s Amicus Therapeutics FOLD Stock Holding History

Wellington Management Group’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,373,867
Closed -$19.6M – 1926
2025
Q4 		$19.6M Sell
1,373,867
-27,254,962
-95% -$268M ﹤0.01% 1043
2025
Q3 		$226M Sell
28,628,829
-495,133
-2% -$3.52M 0.04% 355
2025
Q2 		$167M Sell
29,123,962
-76,655
-0.3% -$495K 0.03% 395
2025
Q1 		$238M Buy
29,200,617
+738,623
+3% +$6.84M 0.05% 306
2024
Q4 		$268M Buy
28,461,994
+4,497,950
+19% +$46.8M 0.05% 299
2024
Q3 		$256M Buy
23,964,044
+2,856,101
+14% +$31.1M 0.04% 340
2024
Q2 		$209M Buy
21,107,943
+2,304,298
+12% +$23.7M 0.04% 370
2024
Q1 		$222M Buy
18,803,645
+3,613,621
+24% +$46.2M 0.04% 372
2023
Q4 		$216M Buy
15,190,024
+7,666,335
+102% +$87M 0.04% 375
2023
Q3 		$91.5M Sell
7,523,689
-296,607
-4% -$3.83M 0.02% 555
2023
Q2 		$98.2M Buy
7,820,296
+305,255
+4% +$3.62M 0.02% 551
2023
Q1 		$83.3M Sell
7,515,041
-592,306
-7% -$7.3M 0.02% 586
2022
Q4 		$99M Buy
8,107,347
+50,972
+0.6% +$574K 0.02% 524
2022
Q3 		$84.1M Sell
8,056,375
-2,968,369
-27% -$33.1M 0.02% 560
2022
Q2 		$118M Sell
11,024,744
-15,594,363
-59% -$128M 0.02% 500
2022
Q1 		$252M Sell
26,619,107
-29,567
-0.1% -$277K 0.04% 359
2021
Q4 		$308M Buy
26,648,674
+2,352,976
+10% +$26.2M 0.05% 334
2021
Q3 		$232M Buy
24,295,698
+8,624,249
+55% +$88.2M 0.04% 404
2021
Q2 		$151M Buy
15,671,449
+1,563,477
+11% +$15.3M 0.03% 518
2021
Q1 		$139M Buy
14,107,972
+3,971,505
+39% +$61.5M 0.02% 512
2020
Q4 		$234M Buy
10,136,467
+4,133,312
+69% +$84.5M 0.04% 378
2020
Q3 		$84.8M Sell
6,003,155
-720,136
-11% -$10.5M 0.02% 564
2020
Q2 		$101M Buy
6,723,291
+2,042,114
+44% +$24.9M 0.02% 519
2020
Q1 		$43.3M Sell
4,681,177
-347,164
-7% -$3.3M 0.01% 677
2019
Q4 		$49M Sell
5,028,341
-2,720,473
-35% -$24.9M 0.01% 752
2019
Q3 		$62.1M Sell
7,748,814
-559,910
-7% -$6.08M 0.01% 670
2019
Q2 		$104M Buy
8,308,724
+595,073
+8% +$7.55M 0.02% 553
2019
Q1 		$105M Buy
7,713,651
+141,689
+2% +$1.73M 0.02% 537
2018
Q4 		$72.5M Buy
7,571,962
+570,592
+8% +$6.27M 0.02% 602
2018
Q3 		$84.6M Sell
7,001,370
-1,094,994
-14% -$15.3M 0.02% 633
2018
Q2 		$126M Sell
8,096,364
-147,969
-2% -$2.24M 0.03% 509
2018
Q1 		$124M Buy
8,244,333
+2,711,202
+49% +$41.3M 0.03% 508
2017
Q4 		$79.6M Sell
5,533,131
-528,603
-9% -$7.26M 0.02% 640
2017
Q3 		$91.4M Buy
6,061,734
+70,926
+1% +$938K 0.02% 569
2017
Q2 		$60.3M Buy
5,990,808
+649,676
+12% +$5.23M 0.01% 671
2017
Q1 		$38.1M Buy
5,341,132
+4,175,995
+358% +$26.4M 0.01% 820
2016
Q4 		$5.79M Buy
1,165,137
+61,020
+6% +$422K ﹤0.01% 1360
2016
Q3 		$8.17M Buy
1,104,117
+15,100
+1% +$102K ﹤0.01% 1247
2016
Q2 		$5.95M Buy
1,089,017
+50,244
+5% +$351K ﹤0.01% 1288
2016
Q1 		$8.78M Sell
1,038,773
-830
-0.1% -$5.88K ﹤0.01% 1188
2015
Q4 		$10.1M Buy
1,039,603
+40,992
+4% +$369K ﹤0.01% 1163
2015
Q3 		$14M Buy
998,611
+10,411
+1% +$163K ﹤0.01% 1075
2015
Q2 		$14M Buy
+988,200
New +$11.9M ﹤0.01% 1134
2013
Q3 		– Sell
-1,422,696
Closed -$3.31M – 2190
2013
Q2 		$3.31M Buy
+1,422,696
New +$4.37M ﹤0.01% 1530

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Wellington Management Group's FOLD Position: Q1 2026 in Review

Wellington Management Group sold out of Amicus Therapeutics (FOLD) in Q1 2026, closing a stake of 1,373,867 shares — an estimated $19.6M sold.

Wellington Management Group first reported a position in FOLD in Q2 2013 and held it in 44 quarters. The position peaked at $308M in Q4 2021. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • Wellington Management Group reported no remaining Amicus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Wellington Management Group sold 1,373,867 Amicus Therapeutics shares in Q1 2026, an estimated $19.6M.
  • Wellington Management Group first reported a position in Amicus Therapeutics in Q2 2013 and held it in 44 quarters.
  • Wellington Management Group's Amicus Therapeutics position peaked at $308M in Q4 2021.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.